Elon Musk lost a staggering $123 billion this year as Tesla’s shares tanked. But he still has a lot of money left

[ad_1]

Elon Musk’s fortune continues to take a beating a week after he lost his spot as the world’s richest person.

His net worth tumbled $7.7 billion on Tuesday after Tesla shares had their steepest one-day loss since October.

The selloff adds to the woes of Musk, who lost his status as the world’s richest person to luxury tycoon Bernard Arnault on Dec. 13. Musk’s losses for the year now total $122.6 billion, exceeding the amount he gained in 2021 when his fortune soared to rank among the biggest in history. The Tesla chief executive officer’s net worth is now $147.7 billion, the lowest in more than two years, according to the Bloomberg Billionaires Index.

Musk’s fortune is primarily comprised of Tesla stock and options. The automaker’s spiraling shares pose a particular risk for Musk, 51, who leveraged more of his position to finance his acquisition of Twitter in October. 

Tesla shareholders have expressed increasing alarm over Musk’s preoccupation with Twitter, which he’s attempting to lead through a messy and public turnaround. He posted a poll on Twitter asking users to vote whether he should step down as head of the social platform. Almost 58% of the 17.5 million respondents said he should.

Our new weekly Impact Report newsletter examines how ESG news and trends are shaping the roles and responsibilities of today’s executives. Subscribe here.

[ad_2]

Source link

Related Posts

Former Domino’s Pizza CEO Richard Allison received nearly $10,000 in free in two years.

[ad_1] Forget having a driver and free dry cleaning. If you want to talk about the ultimate executive perk, look no further than former Domino’s Pizza CEO…

Meta to lay off 10,000 more workers after initial cuts in November

[ad_1] Facebook Chairman and CEO Mark Zuckerberg testifies before the House Financial Services Committee on “An Examination of Facebook and Its Impact on the Financial Services and…

Puma Biotech Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology By Investing.com

[ad_1] Puma Biotech (PBYI) Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology Puma Biotechnology, Inc. (NASDAQ:), a biopharmaceutical company, announced that the results…

Joe Biden to visit Ireland on anniversary of Good Friday Agreement

[ad_1] US president Joe Biden has said it is his “intention” to go to Northern Ireland to mark the 25th anniversary of the Good Friday Agreement, after…

Biden’s ability to avert SVB contagion will test his claim that his administration represents competence in contrast to Trump’s chaos

[ad_1] In 2016, Vice President Joe Biden warned against efforts to unravel banking regulations that Democrats had fought to implement following the nation’s financial crisis, just as the…

Credit Suisse shares sink further 5% as ‘material weaknesses’ found in financial reporting

[ad_1] The logo of Credit Suisse Group in Davos, Switzerland, on Monday, Jan. 16, 2023. Bloomberg | Bloomberg | Getty Images Credit Suisse on Tuesday said its…

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: